Your browser doesn't support javascript.
loading
Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.
Jannoo, Riaz; Xia, Zhidao; Row, Paula E; Kanamarlapudi, Venkateswarlu.
Affiliation
  • Jannoo R; UCL ECMC GCLP Facility, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
  • Xia Z; Institute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
  • Row PE; Institute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
  • Kanamarlapudi V; Institute of Life Science, School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, UK.
Biomolecules ; 13(2)2023 02 12.
Article in En | MEDLINE | ID: mdl-36830725
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Interleukin-13 Receptor alpha2 Subunit / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Biomolecules Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Interleukin-13 Receptor alpha2 Subunit / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Biomolecules Year: 2023 Document type: Article Affiliation country: Country of publication: